{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260817660841/en/Amylyx-Pharmaceuticals-to-Announce-Topline-Results-from-its-Phase-3-LUCIDITY-Clinical-Trial-of-Avexitide-in-Post-Bariatric-Hypoglycemia-on-August-18-2026", "message": "News view counter 887685 successfully enlarged"}